Stayte S, Rentsch P, Troscher A, Bamberger M, Li K, Vissel B
PLoS One. 2017; 12(1):e0167211.
PMID: 28121982
PMC: 5266209.
DOI: 10.1371/journal.pone.0167211.
Tian L, Xia Y, Flores H, Campbell M, Moerlein S, Perlmutter J
PLoS One. 2015; 10(7):e0132064.
PMID: 26135399
PMC: 4489892.
DOI: 10.1371/journal.pone.0132064.
Kadar H, Le Douaron G, Amar M, Ferrie L, Figadere B, Touboul D
Neurotox Res. 2013; 25(1):135-45.
PMID: 24347373
DOI: 10.1007/s12640-013-9449-5.
Dhanushkodi A, Akano E, Roguski E, Xue Y, Rao S, Matta S
Genes Brain Behav. 2012; 12(2):224-33.
PMID: 23190369
PMC: 4360975.
DOI: 10.1111/gbb.12001.
Ansah T, Ferguson M, Nayyar T, Deutch A
Neurosci Lett. 2011; 504(2):160-164.
PMID: 21964387
PMC: 3210582.
DOI: 10.1016/j.neulet.2011.09.026.
Kynurenines in Parkinson's disease: therapeutic perspectives.
Zadori D, Klivenyi P, Toldi J, Fulop F, Vecsei L
J Neural Transm (Vienna). 2011; 119(2):275-83.
PMID: 21858430
DOI: 10.1007/s00702-011-0697-3.
Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
Muthian G, Mackey V, King J, Charlton C
Neuroscience. 2010; 169(3):1085-93.
PMID: 20540993
PMC: 2914187.
DOI: 10.1016/j.neuroscience.2010.04.080.
MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations.
Laloux C, Derambure P, Kreisler A, Houdayer E, Brueziere S, Bordet R
Exp Brain Res. 2008; 186(4):635-42.
PMID: 18224307
DOI: 10.1007/s00221-008-1268-1.
Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences.
Banerjee R, Sreetama S, Saravanan K, Dey S, Mohanakumar K
Neurochem Res. 2007; 32(7):1238-47.
PMID: 17401660
DOI: 10.1007/s11064-007-9299-8.
Restoration and putative protection in Parkinsonism.
Archer T, Fredriksson A
Neurotox Res. 2006; 2(2-3):251-92.
PMID: 16787845
DOI: 10.1007/BF03033798.
1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide.
Kalivendi S, Kotamraju S, Cunningham S, Shang T, Hillard C, Kalyanaraman B
Biochem J. 2003; 371(Pt 1):151-64.
PMID: 12523938
PMC: 1223270.
DOI: 10.1042/BJ20021525.
Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism.
Mandir A, Przedborski S, Jackson-Lewis V, Wang Z, Simbulan-Rosenthal C, Smulson M
Proc Natl Acad Sci U S A. 1999; 96(10):5774-9.
PMID: 10318960
PMC: 21936.
DOI: 10.1073/pnas.96.10.5774.
Short-term manganese pretreatment partially protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
Rojas P, Rios C
Neurochem Res. 1995; 20(10):1217-23.
PMID: 8746808
DOI: 10.1007/BF00995386.
Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson V, Dawson T
Proc Natl Acad Sci U S A. 1996; 93(10):4565-71.
PMID: 8643444
PMC: 39317.
DOI: 10.1073/pnas.93.10.4565.
Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas.
Marzatico F, Cafe C, Taborelli M, Benzi G
Neurochem Res. 1993; 18(10):1101-6.
PMID: 8255359
DOI: 10.1007/BF00966691.
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain.
Javitch J, Uhl G, Snyder S
Proc Natl Acad Sci U S A. 1984; 81(14):4591-5.
PMID: 6611553
PMC: 345637.
DOI: 10.1073/pnas.81.14.4591.
Electrophysiological and neurochemical correlates of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.
Jonsson G, Sundstrom E, Mefford I, Olson L, Johnson S, Freedman R
Naunyn Schmiedebergs Arch Pharmacol. 1985; 331(1):1-6.
PMID: 3877877
DOI: 10.1007/BF00498844.
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
Javitch J, DAmato R, Strittmatter S, Snyder S
Proc Natl Acad Sci U S A. 1985; 82(7):2173-7.
PMID: 3872460
PMC: 397515.
DOI: 10.1073/pnas.82.7.2173.
Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidine.
Mihatsch W, Russ H, Przuntek H
J Neural Transm. 1988; 71(3):177-88.
PMID: 3128644
DOI: 10.1007/BF01245711.
The interaction of 1-alkyl-4,4-diphenylpiperidines with the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine receptor binding site.
Russ H, Pindur U, Przuntek H
J Neural Transm. 1986; 65(3-4):157-66.
PMID: 3011983
DOI: 10.1007/BF01249078.